Glucoside- and Rutinoside-rich Crude Material for Relieving Side Effects of COVID-19 Vaccines

Clinical trial NCT05387252 · UNKNOWN

Trial details

NCT number: NCT05387252
Sponsor: Taipei Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Vaccine Adverse Reaction Side-Effect

Start date: 2022-05-31
Primary completion: 2022-12-31
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.